Journal
NUCLEIC ACIDS RESEARCH
Volume 38, Issue 9, Pages 2839-2850Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkq012
Keywords
-
Categories
Funding
- Nutrigenomics Consortium
- European Nutrigenomics Organisation
- Graduate School VLAG
Ask authors/readers for more resources
The transcription factor peroxisome proliferator-activated receptor alpha (PPAR alpha) is an important regulator of hepatic lipid metabolism. While PPAR alpha is known to activate transcription of numerous genes, no comprehensive picture of PPAR alpha binding to endogenous genes has yet been reported. To fill this gap, we performed Chromatin immunoprecipitation (ChIP)-chip in combination with transcriptional profiling on HepG2 human hepatoma cells treated with the PPAR alpha agonist GW7647. We found that GW7647 increased PPAR alpha binding to 4220 binding regions. GW7647-induced binding regions showed a bias around the transcription start site and most contained a predicted PPAR binding motif. Several genes known to be regulated by PPAR alpha, such as ACOX1, SULT2A1, ACADL, CD36, IGFBP1 and G0S2, showed GW7647-induced PPAR alpha binding to their promoter. A GW7647-induced PPAR alpha-binding region was also assigned to SREBP-targets HMGCS1, HMGCR, FDFT1, SC4MOL, and LPIN1, expression of which was induced by GW7647, suggesting cross-talk between PPAR alpha and SREBP signaling. Our data furthermore demonstrate interaction between PPAR alpha and STAT transcription factors in PPAR alpha-mediated transcriptional repression, and suggest interaction between PPAR alpha and TBP, and PPAR alpha and C/EBP alpha in PPAR alpha-mediated transcriptional activation. Overall, our analysis leads to important new insights into the mechanisms and impact of transcriptional regulation by PPAR alpha in human liver and highlight the importance of cross-talk with other transcription factors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available